A visual comparison of Robert Califf’s US FDA Commissioner confirmation votes in 2016 and 2022.
Robert Califf just made it over the finish line 15 February with a 50-46 Senate confirmation vote to be US Food and Drug Administration Commissioner.
The vote was hardly the resoundingly positive 89-4 vote that secured him the job under President Barack Obama in 2016.
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
